PositoAI

a positivity index

Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights

Latest News

IRulya Therapeutics Inc.

Form 144 IRULYA THERAPEUTICS INC For: 21 October By Investing.com
Investing.com India · 21 Oct 2026
IRulya Therapeutics Inc. Advanced Charts | IRLA
Barron's · 12 Oct 2026
Total revenue of IRulya Therapeutics Inc. – NASDAQ:IRLA
TradingView · 12 Oct 2026
IRulya Therapeutics Inc. Balance Sheet – NASDAQ:IRLA
TradingView · 12 Oct 2026
IRulya Therapeutics Inc. Income Statement – NASDAQ:IRLA
TradingView · 12 Oct 2026
IRulya Therapeutics Inc. Statistics – NASDAQ:IRLA
TradingView · 12 Oct 2026
IRulya Therapeutics Inc. Financial Statements – NASDAQ:IRLA
TradingView · 12 Oct 2026
Quince relaunches as IRulya, going all in on lung disease after Hail Mary merger
Fierce Pharma · 09 Oct 2026
Quince Therapeutics - Changes Name To Irulya Therapeutics
TradingView · 09 Oct 2026
Quince Therapeutics rebrands as IRulya, names new CEO
Investing.com · 09 Oct 2026
Quince Therapeutics Relaunches as IRulya Therapeutics with
GlobeNewswire · 09 Oct 2026
Quince Therapeutics, Inc. has Changed its Name to IRulya Therapeutics Inc
www.marketscreener.com · 09 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.